BIOMAT Database Logo BIOMAT Database Logo

Abnormal DNA end-joining activity in human head and neck cancer. 2006

Ki-Hyuk Shin, and Mo K Kang, and Reuben H Kim, and Ayako Kameta, and Marcel A Baluda, and No-Hee Park
UCLA School of Dentistry, Los Angeles, CA 90095-1668, USA.

In human cells, DNA double-strand breaks (DSBs) are repaired primarily by the DNA end-joining (EJ) process and thus, abnormal DNA EJ activities lead to an accumulation of mutations and/or aneuploidy, resulting in genetic instability of cells. Since genetic instability is the hallmark of cancer cells, we studied the DNA EJ activities of normal, non-malignant immortalized and malignant human epithelial cells to investigate the association between DNA EJ and carcinogenesis. We found a significant diminution of precise (error-free) DNA EJ activities in non-malignant immortalized human oral keratinocytes (HOK-16B) and human head and neck squamous cell carcinoma (HNSCC) cells compared to that in normal human oral keratinocytes (NHOK). Moreover, abnormal DNA EJ activities were detected exclusively in HOK-16B and HNSCC cells due to microhomology-mediated and non-microhomology-mediated end-joining activities in these cells. These data indicated that aberrant DNA EJ activity may be partly responsible for genetic instability and oncogenic transformation.

UI MeSH Term Description Entries
D008156 Luciferases Enzymes that oxidize certain LUMINESCENT AGENTS to emit light (PHYSICAL LUMINESCENCE). The luciferases from different organisms have evolved differently so have different structures and substrates. Luciferase
D008957 Models, Genetic Theoretical representations that simulate the behavior or activity of genetic processes or phenomena. They include the use of mathematical equations, computers, and other electronic equipment. Genetic Models,Genetic Model,Model, Genetic
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D002472 Cell Transformation, Viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. Transformation, Viral Cell,Viral Cell Transformation,Cell Transformations, Viral,Transformations, Viral Cell,Viral Cell Transformations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response

Related Publications

Ki-Hyuk Shin, and Mo K Kang, and Reuben H Kim, and Ayako Kameta, and Marcel A Baluda, and No-Hee Park
TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.
July 2014, Nature communications,
Ki-Hyuk Shin, and Mo K Kang, and Reuben H Kim, and Ayako Kameta, and Marcel A Baluda, and No-Hee Park
Corrigendum: TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.
February 2016, Nature communications,
Ki-Hyuk Shin, and Mo K Kang, and Reuben H Kim, and Ayako Kameta, and Marcel A Baluda, and No-Hee Park
The role of DNA polymerase activity in human non-homologous end joining.
August 2001, Nucleic acids research,
Ki-Hyuk Shin, and Mo K Kang, and Reuben H Kim, and Ayako Kameta, and Marcel A Baluda, and No-Hee Park
DNA end-joining in extracts from human cells.
October 1995, Biochemical and biophysical research communications,
Ki-Hyuk Shin, and Mo K Kang, and Reuben H Kim, and Ayako Kameta, and Marcel A Baluda, and No-Hee Park
DNA end joining activity is reduced in Alzheimer's disease.
April 2006, Neurobiology of aging,
Ki-Hyuk Shin, and Mo K Kang, and Reuben H Kim, and Ayako Kameta, and Marcel A Baluda, and No-Hee Park
Human transcriptional coactivator PC4 stimulates DNA end joining and activates DSB repair activity.
January 2009, Journal of molecular biology,
Ki-Hyuk Shin, and Mo K Kang, and Reuben H Kim, and Ayako Kameta, and Marcel A Baluda, and No-Hee Park
Dysfunctional activity of classical DNA end-joining renders acquired resistance to carboplatin in human ovarian cancer cells.
November 2021, Cancer letters,
Ki-Hyuk Shin, and Mo K Kang, and Reuben H Kim, and Ayako Kameta, and Marcel A Baluda, and No-Hee Park
The mechanism of human nonhomologous DNA end joining.
January 2008, The Journal of biological chemistry,
Ki-Hyuk Shin, and Mo K Kang, and Reuben H Kim, and Ayako Kameta, and Marcel A Baluda, and No-Hee Park
Human papillomavirus associated XPF deficiency increases alternative end joining and cisplatin sensitivity in head and neck squamous cell carcinoma.
May 2023, Oral oncology,
Ki-Hyuk Shin, and Mo K Kang, and Reuben H Kim, and Ayako Kameta, and Marcel A Baluda, and No-Hee Park
Mechanism and regulation of human non-homologous DNA end-joining.
September 2003, Nature reviews. Molecular cell biology,
Copied contents to your clipboard!